#ACTRIMS26: Sanofi unpacks data from a failed Phase 3 tolebrutinib trial in PPMS
#ACTRIMS26：赛诺菲公布一项失败的III期tolebrutinib在原发进展型multiple sclerosis (PPMS)中的试验数据

Sanofi has raised the curtain on data from an unsuccessful Phase 3 BTK inhibitor trial, which led to the company retreating from a form of multiple sclerosis.
赛诺菲公布了一项失败的III期BTK抑制剂试验的数据，这促使公司从某一种multiple sclerosis的治疗领域撤退。